Neogen Corporation Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Neogen Corporation (NEOG) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $23.10 million as of 2023-02-28, per its 10-Q filed 2023-04-04.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2023-04-04
- 2023-02-28: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $23.10M.
- 2022-11-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $45.60M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2023-02-28 | $23.10M 10-Q · filed 2023-04-04 |
| 2022-11-30 | $45.60M 10-Q · filed 2023-01-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |